A plain language summary describing how two different concentrations of GP2017, a biosimilar adalimumab medicine, are associated with similar drug levels within the body.
- Resource Type
- Article
- Source
- Immunotherapy (1750743X); Dec2023, Vol. 15 Issue 18, p1501-1509, 9p
- Subject
- Language
- ISSN
- 1750743X